Printer Friendly

RESEARCH REPORT ON ALBA, LEADING SPANISH CONGLOMERATE

 MADRID, Spain, Jan. 13 /PRNewswire/ -- A new research report covering Corporacion Financiera Alba, Spain's first and largest publicly-traded conglomerate, is now available from LINK SECURITIES AVB in Madrid.
 The report was prepared by the Axel Group, one of Spain's leading independent research and financial analysis firms.
 LINK SECURITIES provides brokerage services on the Madrid Stock Exchange primarily for institutional clients in Spain and the U.S. It holds exclusive rights to U.S. distribution of all Axel Group research reports.
 For further information, inquiries should be directed to: LINK SECURITIES AVB Paseo De La Castellana 130, 28046 Madrid, Spain.
 -0- 1/13/93
 /CONTACT: Manuel Enrich, of LINK SECURITIES, 011-34-1-562-6348; or Frank Della Corte, of Wattel/Della Corte & Arkin, 212-599-2369, for LINK SECURITIES/


CO: Corporacion Financiera Alba ST: IN: SU: ECO

LR -- NY019 -- 4397 01/13/93 10:27 EST
COPYRIGHT 1993 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1993 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Jan 13, 1993
Words:140
Previous Article:NEWS AMERICA FSI, KRAFT GENERAL FOODS, AGREES TO A TWO-YEAR DEAL; POSSIBLE TIE-INS TO FOX PROPERTIES CONSIDERED
Next Article:SPECTRUM INFORMATION TECHNOLOGIES, INC. ANNOUNCES BREAKTHROUGH IN DATA TRANSMISSION ON CELLULAR SYSTEM, COMPANY FILES FOR PATENT
Topics:


Related Articles
SIGNET BANKING CORPORATION FILES REGISTRATION STATEMENT FOR SECONDARY OFFERING OF COMMON STOCK OWNED BY CORPORACION FINANCIERA ALBA
ALBA-WALDENSIAN PROMOTES BROSY AND OSBORNE
WITNESS DENIES ROMANCE WITH SLAIN MAN.
PROSECUTION DISPUTES ABUSE BEFORE SLAYING.
Planeta to publish Cisneros biography.
Alba Therapeutics Acquires Zonulin Technologies from UMB; 100 Patents Go to Baltimore-based BioPharmaceutical Company.
Alba Therapeutics Announces the Appointment of Allen Sedman, MD, PhD to Scientific Advisory Board.
The Duke of Alba.
Alba Therapeutics Appoints Dr. Linda Arterburn to Head Pharmacology and Toxicology Department.

Terms of use | Copyright © 2017 Farlex, Inc. | Feedback | For webmasters